The FDA and graphic cigarette-pack warnings - Thwarted by the courts

New England Journal of Medicine

Volumn 369, Issue 3, 2013, Pages 206-208

  Bayer, Ronald ^a   Johns, David ^a   Colgrove, James ^a  

^a Mailman School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; BEHAVIORAL SCIENCE; CONSUMER HEALTH INFORMATION; COST BENEFIT ANALYSIS; COURT; EMOTION; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; GRAPHIC CIGARETTE PACK WARNING; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY; SMOKING REGULATION; SOCIOLOGY;

EID: 84880436469     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1306205     Document Type: Article

References (5)

1. Holder E Jr. Letter to the Honorable John Boehner, Re: R.J. Reynolds v. Food & Drug Administration, No. 11-5332 (D.C. Cir.). March 15, 2013 (http://www.mainjustice.com/files/2013/03/Ltr-to-Speaker-re-Reynolds-v-FDA.pdf).
2. Glantz S. The FDA made the right decision not to appeal the current warning labels. 2013 (http://tobacco.ucsf.edu/fda-made-right-decision-not- appeal-current-warning-labels).
3. Hammond D. Health warning messages on tobacco products: a review. Tob Control 2011;20:327-37.
4. Azagba S, Sharaf MF. The effect of graphic cigarette warning labels on smoking behavior: evidence from the Canadian experience. Nicotine Tob Res 2013;15:708-17.
5. Wins and losses in the fight against tobacco. New York Times. April 28, 2013.